Blog
RSS FeedPosted by Michael Wonder on 08 Apr 2019
Prostate cancer hormone therapy rejected on NHS in England
8 April 2019 - A prostate cancer drug won't be offered on the NHS any earlier in the treatment plans of ...
Posted by Michael Wonder on 07 Apr 2019
NICE appraisal for BMS kidney cancer immunotherapy combination
5 April 2019 - NICE has issued a Final Appraisal Determination endorsing NHS use of an Opdivo (nivolumab) and Yervoy ...
Posted by Michael Wonder on 02 Apr 2019
NICE nod for breast cancer delay drug
2 April 2019 - NICE has recommended Eli Lilly’s Verzenio (abemaciclib) when given with Faslodex (fulvestrant), to be available for ...
Posted by Michael Wonder on 28 Mar 2019
Promising lung cancer treatment approved for Cancer Drugs Fund
28 March 2019 - A promising new lung cancer treatment will be available on the NHS through the Cancer Drugs Fund, ...
Posted by Michael Wonder on 23 Mar 2019
NICE nod for Takeda’s Adcetris in advanced stage CTCL
22 March 2019 - Takeda has announced the NICE recommendation of its advanced cutaneous T-cell lymphoma drug Adcetris (brentuximab vedotin). ...
Posted by Michael Wonder on 21 Mar 2019
NICE terminates yet another assessment of a cancer medicine
20 March 2019 - This time it is pembrolizumab (Keytruda). ...
Posted by Michael Wonder on 20 Mar 2019
York man Paul Thomas-Peter says he could die because NHS won't fund drug
19 March 2019 - A York cancer patient says he could die because the NHS refuses to fund immunotherapy treatment ...
Posted by Michael Wonder on 14 Mar 2019
One in four cancer patients wait two months for treatment, as NHS performance hits record low
14 March 2019 - The number of cancer sufferers waiting at least two months for treatment after an urgent referral ...
Posted by Michael Wonder on 14 Mar 2019
UK breast cancer patients win early access to Tecentriq/nab-paclitaxel
14 March 2019 - Adults in the UK with PD-L1 positive, unresectable locally advanced or metastatic triple-negative breast cancer have ...
Posted by Michael Wonder on 13 Mar 2019
Cancer patient denied life-prolonging drug as she lives half a mile outside England
13 March 2019 - A seriously ill mum-of-two has spoken of her devastation after being denied a life prolonging cancer drug ...
Posted by Michael Wonder on 12 Mar 2019
NICE u-turn backs use of Darzalex combo for myeloma relapse
12 March 2019 - Myeloma patients in England are set to gain NHS access to a new second-line treatment combination ...
Posted by Michael Wonder on 06 Mar 2019
NICE evidence request for Blincyto for acute lymphoblastic leukaemia
6 March 2019 - NICE has requested further evidence on Amgen’s Blincyto (blinatumomab) for the treatment of adults with acute ...
Posted by Michael Wonder on 25 Feb 2019
Family fight for cancer treatment in USA because drugs not available in UK
25 February 2019 - A mother of four from Downham Market in west Norfolk says she won't live to 50 ...
Posted by Michael Wonder on 21 Feb 2019
Linking cancer drug prices to treatment success could speed up approvals. But what do patients consider success?
21 February 2019 - The NHS spends more than £2 billion on cancer drugs each year in the UK. And ...
Posted by Michael Wonder on 20 Feb 2019
NICE terminates appraisal of combination regimen for patients with advanced platinum-sensitive ovarian cancer
20 February 2019 - The treatment regimen is bevacizumab with carboplatin and gemcitabine hydrochloride and paclitaxel. ...